FDA NDC Directory · JSON-LD · Markdown

Sugammadex

NDC 70771-1856 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA214290
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsSUGAMMADEX SODIUM (200 mg/2mL)
Marketing started20260702
Package count1

External sources

Source: openFDA. Public-domain (CC0).